Your opinion:
"Hence, to avoid arbitrage, investors are selling Livent to buy Allkem, explaining the charts."
is illogical and demonstrates your limited ability to read charts and how to interpret their meaning!
Hint: Look at the X axis showing time and assess when the divergence of AKE overperformance and Livent underperformance to their respective peer indices started.
Yes, the divergence started well before the merger was announced.
Also, a few years back Livent was valued higher than its peers....and then things turned south.
What corporate event coincided with Livent going from outperforming to underperforming?
@tt2000 your opinion on the subject of the merger adds no value to the debate because you do not take the time and effort to substantiate anything you say with facts.
"Wasting electrons on factless posts is like burning candles in broad daylight – a futile expenditure of energy that sheds no real light."
(Proverb, schmunzel75, 09.12.2023)
Doing the right thing and saving the energy waste and Co2 emissions related to your useless posts, on IGNORE you go.
AKE Price at posting:
$9.16 Sentiment: Buy Disclosure: Held
